CRISPR gene editing has been hailed as a breakthrough for treating genetic diseases, but the long-term effects on human embryos are still unknown. I read about a recent trial where edited cells persisted for years without issues, yet we can't rule out off-target mutations causing cancer later. Should we allow germline editing in clinics before we fully understand the risks, or is the precautionary principle too costly for patients who have no other options?